98 related articles for article (PubMed ID: 9328216)
1. Safety and kinetic properties of a humanized antibody to human interleukin-6 receptor in healthy non-human primates.
Shinkura H; Imazeki I; Fukushima N; Chiba N; Takahashi F; Aikawa H; Kitamura H; Furuichi T; Horiba N; Ohsugi Y
Toxicology; 1997 Oct; 122(3):163-70. PubMed ID: 9328216
[TBL] [Abstract][Full Text] [Related]
2. In vivo blocking effects of a humanized antibody to human interleukin-6 receptor on interleukin-6 function in primates.
Shinkura H; Imazeki I; Yamazaki M; Oda Y; Kotoh M; Mihara M
Anticancer Res; 1998; 18(2A):1217-21. PubMed ID: 9615791
[TBL] [Abstract][Full Text] [Related]
3. IL-6 functions in cynomolgus monkeys blocked by a humanized antibody to human IL-6 receptor.
Imazeki I; Saito H; Hasegawa M; Shinkura H; Kishimoto T; Ohsugi Y
Int J Immunopharmacol; 1998 Jul; 20(7):345-57. PubMed ID: 9756130
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
Stubenrauch K; Wessels U; Lenz H
J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
[TBL] [Abstract][Full Text] [Related]
5. New xenograft model of multiple myeloma and efficacy of a humanized antibody against human interleukin-6 receptor.
Tsunenari T; Koishihara Y; Nakamura A; Moriya M; Ohkawa H; Goto H; Shimazaki C; Nakagawa M; Ohsugi Y; Kishimoto T; Akamatsu K
Blood; 1997 Sep; 90(6):2437-44. PubMed ID: 9310495
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of humanized anti-interleukin-6 receptor antibody: antitumor activity in xenograft model of multiple myeloma.
Tsunenari T; Akamatsu K; Kaiho S; Sato K; Tsuchiya M; Koishihara Y; Kishimoto T; Ohsugi Y
Anticancer Res; 1996; 16(5A):2537-44. PubMed ID: 8917348
[TBL] [Abstract][Full Text] [Related]
7. Natural antibodies against the immunoglobulin F(ab')2 fragment cause elimination of antigens recognized by the F(ab')2 from the circulation.
Yano S; Kaku S; Suzuki K; Terazaki C; Sakayori T; Kawasaki T; Kawamura K; Sugita Y; Hoshino K; Masuho Y
Eur J Immunol; 1995 Nov; 25(11):3128-33. PubMed ID: 7489753
[TBL] [Abstract][Full Text] [Related]
8. Effects of SA237, a humanized anti-interleukin-6 receptor monoclonal antibody, on pre- and postnatal development in cynomolgus monkey.
Katagiri R; Ishihara-Hattori K; Frings W; Amano J; Fuchs A; Chiba S
Birth Defects Res; 2017 Jul; 109(11):843-856. PubMed ID: 28504465
[TBL] [Abstract][Full Text] [Related]
9. Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma.
Hart TK; Blackburn MN; Brigham-Burke M; Dede K; Al-Mahdi N; Zia-Amirhosseini P; Cook RM
Clin Exp Immunol; 2002 Oct; 130(1):93-100. PubMed ID: 12296858
[TBL] [Abstract][Full Text] [Related]
10. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to rat soluble IL-6 receptor stimulate B9 hybridoma cell proliferation.
Thibault V; Richards CD; Botelho F; Gauldie J
FEBS Lett; 1997 May; 408(2):182-6. PubMed ID: 9187363
[TBL] [Abstract][Full Text] [Related]
12. Off-target platelet activation in macaques unique to a therapeutic monoclonal antibody.
Santostefano MJ; Kirchner J; Vissinga C; Fort M; Lear S; Pan WJ; Prince PJ; Hensley KM; Tran D; Rock D; Vargas HM; Narayanan P; Jawando R; Rees W; Reindel JF; Reynhardt K; Everds N
Toxicol Pathol; 2012 Aug; 40(6):899-917. PubMed ID: 22552394
[TBL] [Abstract][Full Text] [Related]
13. [Clinical application of interleukin-6 receptor antibody].
Nishimoto N; Shima Y; Sasai M; Danno N; Yoshizaki K
Nihon Rinsho Meneki Gakkai Kaishi; 1997 Apr; 20(2):87-94. PubMed ID: 9280606
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice.
Tsujinaka T; Fujita J; Ebisui C; Yano M; Kominami E; Suzuki K; Tanaka K; Katsume A; Ohsugi Y; Shiozaki H; Monden M
J Clin Invest; 1996 Jan; 97(1):244-9. PubMed ID: 8550842
[TBL] [Abstract][Full Text] [Related]
15. Impact of molecular processing in the hinge region of therapeutic IgG4 antibodies on disposition profiles in cynomolgus monkeys.
Stubenrauch K; Wessels U; Regula JT; Kettenberger H; Schleypen J; Kohnert U
Drug Metab Dispos; 2010 Jan; 38(1):84-91. PubMed ID: 19850673
[TBL] [Abstract][Full Text] [Related]
16. An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody.
Breslin WJ; Hilbish KG; Martin JA; Halstead CA; Newcomb DL; Chellman GJ
Birth Defects Res B Dev Reprod Toxicol; 2015 Jun; 104(3):100-16. PubMed ID: 26195230
[TBL] [Abstract][Full Text] [Related]
17. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
18. Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samples.
Stubenrauch K; Wessels U; Essig U; Kowalewsky F; Vogel R; Heinrich J
J Pharm Biomed Anal; 2013 Jan; 72():208-15. PubMed ID: 23017233
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis.
Quan JM; Martin TR; Rosenberg GB; Foster DC; Whitmore T; Goodman RB
Biochem Biophys Res Commun; 1996 Feb; 219(2):405-11. PubMed ID: 8605000
[TBL] [Abstract][Full Text] [Related]
20. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.
Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M
Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
